Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdolhossein Zarrin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|January 25, 2014
Carrier erythrocytes: recent advances, present status, current trends and future horizonsAbdolhossein Zarrin, Mahshid Foroozesh, Mehrdad Hamidi
Critical Reviews in Biotechnology|September 13, 2007
Novel delivery systems for interferonsMehrdad Hamidi, Abdolhossein Zarrin, Mahshid Foroozesh
Critical Reviews in Therapeutic Drug Carrier Systems|April 12, 2007
Lipoproteins: from physiological roles to drug delivery potentialsMehrdad Hamidi, Mahshid Foroozesh, Abdolhossein Zarrin
Chemical Biology & Drug Design|October 8, 2010
Dihydropyridines and multidrug resistance: previous attempts, present state, and future trendsAbdolhossein Zarrin, Ahmad R Mehdipour, Ramin Miri
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 3, 2006
A simple and rapid HPLC method for quantitation of interferon-alpha2b in dosage forms and delivery systemsAbdolhossein Zarrin, Mahshid Foroozesh, Mehrdad Hamidi, et al.
Drug Delivery|July 7, 2007
Preparation and validation of carrier human erythrocytes loaded by bovine serum albumin as a model antigen/proteinMehrdad Hamidi, Najmeh Zarei, Abdolhossein Zarrin, et al.
International Journal of Pharmaceutics|January 2, 2016
Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapyAbdolhossein Zarrin, Somayeh Sadighian, Kobra Rostamizadeh, et al.
European Journal of Medicinal Chemistry|December 4, 2012
2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agentsMohammad Azizmohammadi, Mehdi Khoobi, Ali Ramazani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|January 25, 2014
Carrier erythrocytes: recent advances, present status, current trends and future horizonsAbdolhossein Zarrin, Mahshid Foroozesh, Mehrdad Hamidi
Critical Reviews in Biotechnology|September 13, 2007
Novel delivery systems for interferonsMehrdad Hamidi, Abdolhossein Zarrin, Mahshid Foroozesh
Critical Reviews in Therapeutic Drug Carrier Systems|April 12, 2007
Lipoproteins: from physiological roles to drug delivery potentialsMehrdad Hamidi, Mahshid Foroozesh, Abdolhossein Zarrin
Chemical Biology & Drug Design|October 8, 2010
Dihydropyridines and multidrug resistance: previous attempts, present state, and future trendsAbdolhossein Zarrin, Ahmad R Mehdipour, Ramin Miri
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 3, 2006
A simple and rapid HPLC method for quantitation of interferon-alpha2b in dosage forms and delivery systemsAbdolhossein Zarrin, Mahshid Foroozesh, Mehrdad Hamidi, et al.
Drug Delivery|July 7, 2007
Preparation and validation of carrier human erythrocytes loaded by bovine serum albumin as a model antigen/proteinMehrdad Hamidi, Najmeh Zarei, Abdolhossein Zarrin, et al.
International Journal of Pharmaceutics|January 2, 2016
Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapyAbdolhossein Zarrin, Somayeh Sadighian, Kobra Rostamizadeh, et al.
European Journal of Medicinal Chemistry|December 4, 2012
2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agentsMohammad Azizmohammadi, Mehdi Khoobi, Ali Ramazani, et al.
Pageof 1